NEW CANAAN, CT, October 27, 2003—The Sabin Vaccine Institute announced the appointment of Nathan Tinker, PhD, as executive director of the Cancer Vaccine Consortium (CVC), a new initiative of the decade- old New Canaan-based non-profit organization. Dr. Tinker, a resident of Norwalk, will be the principal organizer of the Consortium program, which works with a growing list of biopharmaceutical companies to advance discovery of new therapies for a range of cancers. Dr.
Administrator of Key Programmatic Area Draws from Business Leadership Expertise
NEW CANAAN, CT—Robert H. Abplanalp, a major sponsor of the Albert B. Sabin Vaccine Institute, died August 30 at his home in Bronxville, NY. He was 81 years old and had cancer.
Businessman, Inventor Was President Nixon’s Friend
NEW CANAAN, CT—Treatment options for a variety of cancers are expanding to include an array of exciting new approaches. Along with well-established companies, newer biotechnology and biopharmaceutical firms are looking to break into an emerging market that would provide vaccines for both solid cancers—such as melanoma, prostate, breast, lung, cervical, colon, brain, and ovarian—and blood borne cancers—such as lymphoma, leukemia, and myeloma.
Cancer Vaccine Consortium Promotes Collaboration to Introduce New Therapeutic Vaccines
WASHINGTON, D.C.— Two recent studies released by the WASHINGTON, D.C.— Two recent studies released by the American Journal of Preventive Medicine and the
Critical research shows no link between vaccines, autism
NEW CANAAN, CT—The Sabin Vaccine Institute presents its highest non-science awards on May 14 to four illustrious groundbreakers in business, social service, and academia. One is the leader of one of the world’s premier pharmaceutical companies, two are collaborators in starting an organization to benefit the nation’s medically underserved children, and a fourth is a prominent university president.
Wyeth’s Bernard Poussot to Be Recognized for Achievement; Children’s Health Fund Founders Pa